Trusted Resources: Education
Scientific literature and patient education texts
Prenatal Diagnosis of Mucopolysaccharidoses Type II by Two-Dimensional Electrophoresis and Mass Spectrometry in Amniotic Fluid
source: The journal of obstetrics and gynaecology research
year: 2022
authors: Aboulnasr AA,Elnouri A,Abdel Sameea G,Gouda AS,Ibrahim MM,Shalabi TA,Gaber KR
summary/abstract:To introduce a quantitative determination of heparan sulfate and dermatan sulfate by mass spectrometry and to compare it with two-dimensional electrophoresis of the glycosaminoglycans in the amniotic fluid for the prenatal diagnosis of mucopolysaccharidoses type II (MPS II).
organization: Prenatal Diagnosis and Fetal Medicine Department, National Research Centre, Giza, Egypt.DOI: 10.1111/jog.15135
read more
BookmarkRelated Content
-
Divergent Developmental Trajectories in Two Siblings With Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome...Mucopolysaccharidosis type II (MPS II; H...
-
Surgical Management of an Aortic Root Dilatation in a Patient Suffering From Hunter SyndromeHunter syndrome is a rare disease leadin...
-
CHOP – Lysosomal Storage Disease (LSD) CenterThe Lysosomal Storage Disease Center at ...
-
iPS-Derived Neural Stem Cells for Disease Modeling and Evaluation of Therapeutics for Mucopolysaccharidosis Type IIMucopolysaccharidosis type II (MPS II), ...
-
A Guide to Understanding MPS IIMPS II is a mucopolysaccharide disease k...
-
Golgi Requires a New Casting in the Screenplay of Mucopolysaccharidosis II CytopathologyLysosome (L), a hydrolytic compartment o...
-
Denali Therapeutics Announces Fast Track Designation Granted by the U.S. FDA to ETV:IDS (DNL310) for the Treatment o...Denali Therapeutics Inc., a biopharmaceu...
Powered by
